Rebecca Limer Associate

Rebecca Limer

Rebecca Limer is an Associate in the Intellectual Property team. Rebecca works across all IP rights and advises clients on a range of contentious and non-contentious matters.

During her training contract Rebecca assisted with a number of patent litigation matters for life sciences and consumer goods clients in a range of UK forums including the Patents Directorate of the UK Intellectual Office, the High Court and Court of Appeal. A highlight of which was Rebecca's role as a junior member of the Gowling WLG team which represented Fujifilm in Fujifilm Kyowa Kirin Biologics Co Ltd v AbbVie [2017] EWHC 395 (Pat). This case resulted in Fujifilm being awarded a declaration confirming the obviousness of its own products, the first of its kind in the UK, which cleared the way for launch of Fujifilm's biosimilar to AbbVie's blockbuster drug, Humira.

Following qualification Rebecca continues to represent clients in patent litigation matters and has also assisted on a range high value IP transactions and corporate deals with an IP element.

Rebecca has previous work experience and a particular interest in the life science sector. Prior to joining the firm Rebecca worked in contract management roles for a multinational healthcare business, where she focused on medical imaging R&D projects, and a leading cancer research charity, where she was responsible for contracting commercially sponsored clinical trials and other industry collaboration agreements.

She has recently obtained a Postgraduate Diploma in Intellectual Property Law and Practice from the University of Oxford.